Urologic Health Raises $11M In Seed Funding

The company plans to use the funding to support clinical validation, continue product and manufacturing development, advance its FDA 510(k) regulatory process, and establish its headquarters in Jersey City, New Jersey.

Bladder conditions such as overactive bladder, urinary retention, incontinence and benign prostatic hyperplasia (BPH) affect hundreds of millions of people worldwide and often require ongoing monitoring and evaluation. However, many current diagnostic methods are invasive, and uncomfortable, causing some patients to delay or avoid testing.

Urologic Health developed the non invasive niu™ System to address this problem. The system is designed to provide detailed bladder function data without the need for catheterization, making routine testing and long-term bladder monitoring easier and more comfortable for patients.

Urologic Health has completed early feasibility studies showing that the niu™ System can non-invasively capture meaningful bladder activity data for clinical use.

"Urologic Health was established through our unique venture creation model, which works together with strategic industry partners to identify needs and address them by bringing together talented entrepreneurs to build high-potential medical device companies," said Shai Policker, Managing Partner of Edge Medical Ventures and chairman of Urologic's board. "By combining exceptional engineering talent in Israel with Edge's operational support, we can help companies like Urologic Health move faster through clinical validation, regulatory execution, and early market entry in the United States."

Read More:Saile Raises $2.2M in Pre-Seed Funding Led by Matchstick Ventures

"Invasive urodynamics remains one of the most significant barriers in modern urological care," said Adam Yaacov, Co-founder, and CEO of Urologic Health. "While treatment options have evolved considerably, the invasive diagnostic process continues to present challenges for patients. Urologic aims to make bladder function assessment easier for clinicians to perform, painless for patients to undergo and more informative for longitudinal decision-making."

About Urologic Health

Founded by Adam Yaacov and Noam Omer, Urologic Health is developing non-invasive technology for assessing bladder function. Its niu™ System is designed to capture clinically useful bladder activity data without catheterization, making bladder testing more routine and repeatable. The founders bring experience in medical technology, AI driven healthcare solutions and data focused clinical innovation.

Read More:equipifi Raises $34M in Series B Funding Led by Left Lane Capital